| Date Filed | Type | Description |
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/05/2022 |
4
| JACOB GARY S (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 12,091 options to buy
@ $3.43, valued at
$41.5k
|
|
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2021 |
4
| JACOB GARY S (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.|
Txns:
| Granted 250,000 options to buy
@ $1.7, valued at
$425k
|
|
| 04/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2021 |
4
| JACOB GARY S (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Bought 3,500 shares
@ $6.789, valued at
$23.8k
|
|
| 02/16/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/01/2020 |
4
| JACOB GARY S (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.|
Txns:
| Bought 12,000 shares
@ $1.66, valued at
$19.9k
|
|
| 08/21/2020 |
4
| JACOB GARY S (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 options
@ $3.72, valued at
$111.6k
|
|
| 06/19/2020 |
4
| JACOB GARY S (Director) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Granted 28,858 options
@ $2.6, valued at
$75k
|
|
| 05/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/07/2020 |
4
| JACOB GARY S (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.|
Txns:
| Granted 60,000 options
@ $1.63, valued at
$97.8k
|
|
| 07/25/2019 |
4
| JACOB GARY S (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.|
Txns:
| Granted 970 options
@ $3.24, valued at
$3.1k
|
|
| 06/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2018 |
4
| JACOB GARY S (Director) has filed a Form 4 on ContraVir Pharmaceuticals, Inc.|
Txns:
| Bought 15 convertible preferred
@ $1000, valued at
$15k
Bought 8,625 warrants
@ $1.55, valued at
$13.4k
|
|
| 06/18/2018 |
4
| JACOB GARY S (Executive Chairman) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 131,934 shares
@ $0
Paid exercise price by delivering 150,246 shares
@ $0
Exercised 474,961 options
@ $0.5, valued at
$237.5k
|
|
| 01/25/2018 |
4
| JACOB GARY S (Director) has filed a Form 4 on Trovagene, Inc.|
Txns:
| Granted 54,322 options
@ $0.3, valued at
$16.3k
|
|
| 01/09/2018 |
4
| JACOB GARY S (Executive Chairman) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.|
Txns:
| Granted 950,000 options
@ $2.18, valued at
$2.1M
|
|
| 01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/05/2017 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
| 01/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/20/2016 |
4
| JACOB GARY S (Director) has filed a Form 4 on ContraVir Pharmaceuticals, Inc. |
| 06/27/2016 |
4
| JACOB GARY S (CEO) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.|
Txns:
| Granted 970,000 options
@ $3.67, valued at
$3.6M
|
|
| 01/06/2016 |
4
| JACOB GARY S (Director) has filed a Form 4 on Trovagene, Inc.|
Txns:
| Granted 16,000 options
@ $5.18, valued at
$82.9k
|
|
| 09/30/2015 |
4
| JACOB GARY S (CEO) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.|
Txns:
| Granted 500,000 options
@ $5.39, valued at
$2.7M
|
|
| 07/28/2015 |
4
| JACOB GARY S (CEO) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.|
Txns:
| Granted 300,000 options
@ $7.91, valued at
$2.4M
|
|
| 07/01/2015 |
4
| JACOB GARY S (CEO) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.|
Txns:
| Exercised 62,965 options
@ $5.61, valued at
$353.2k
|
|
| 03/19/2015 |
4
| JACOB GARY S (Director) has filed a Form 4 on Trovagene, Inc.|
Txns:
| Granted 16,000 options
@ $7.18, valued at
$114.9k
|
|
|